Teachers Advisors LLC raised its stake in AxoGen, Inc. (NASDAQ:AXGN) by 25.5% during the fourth quarter, Holdings Channel reports. The fund owned 48,740 shares of the medical equipment provider’s stock after buying an additional 9,893 shares during the period. Teachers Advisors LLC owned 0.15% of AxoGen worth $439,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in AXGN. Metropolitan Life Insurance Co. NY boosted its position in AxoGen by 17.3% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 19,903 shares of the medical equipment provider’s stock valued at $179,000 after buying an additional 2,935 shares during the last quarter. AQR Capital Management LLC acquired a new position in AxoGen during the fourth quarter valued at about $180,000. Menta Capital LLC boosted its position in AxoGen by 19.2% in the fourth quarter. Menta Capital LLC now owns 102,538 shares of the medical equipment provider’s stock valued at $923,000 after buying an additional 16,530 shares during the last quarter. Russell Investments Group Ltd. acquired a new position in AxoGen during the fourth quarter valued at about $1,963,000. Finally, State Street Corp boosted its position in AxoGen by 12.8% in the fourth quarter. State Street Corp now owns 352,735 shares of the medical equipment provider’s stock valued at $3,175,000 after buying an additional 39,963 shares during the last quarter. 64.93% of the stock is owned by institutional investors.
AxoGen, Inc. (NASDAQ AXGN) opened at 14.75 on Friday. AxoGen, Inc. has a 52 week low of $5.86 and a 52 week high of $16.00. The company’s market cap is $488.15 million. The company’s 50-day moving average price is $14.12 and its 200 day moving average price is $11.05.
AxoGen (NASDAQ:AXGN) last released its earnings results on Thursday, May 4th. The medical equipment provider reported ($0.11) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.10) by $0.01. The firm had revenue of $12.24 million during the quarter, compared to analyst estimates of $11.83 million. AxoGen had a negative net margin of 32.05% and a negative return on equity of 155.78%. On average, analysts anticipate that AxoGen, Inc. will post ($0.31) EPS for the current year.
COPYRIGHT VIOLATION WARNING: “AxoGen, Inc. (AXGN) Stake Boosted by Teachers Advisors LLC” was originally posted by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.wkrb13.com/markets/2229499/axogen-inc-axgn-stake-boosted-by-teachers-advisors-llc.html.
Several research analysts have recently issued reports on AXGN shares. Roth Capital started coverage on AxoGen in a research note on Monday, March 6th. They issued a “buy” rating and a $14.50 price target for the company. ValuEngine raised AxoGen from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Wedbush reissued an “outperform” rating and issued a $14.00 price target (down previously from $17.00) on shares of AxoGen in a research note on Friday, May 19th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $13.17.
Want to see what other hedge funds are holding AXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AxoGen, Inc. (NASDAQ:AXGN).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229499/axogen-inc-axgn-stake-boosted-by-teachers-advisors-llc.html
Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.